Immunotherapy for
oncological diseases
We teach your own immune system to recognize tumour cells. The method is used alongside standard treatment, including at advanced stages.
Adaptation of cancer cells
Two factors limiting the effectiveness of standard chemotherapy and radiotherapy.
Immune masking
Tumour cells secrete proteins that suppress T-lymphocyte activity. The immune system stops recognizing the altered tissue as a threat and takes metastases for the body's own healthy cells. This is how a «cold» tumour arises, one the natural defences do not see.
Cellular resistance
Chemotherapy and radiation kill tumour cells but at the same time deplete the body's immune resources. Surviving cells eventually develop resistance to the drugs and adapt to them, so the effectiveness of standard regimens gradually falls.
We train immunity outside the body,
where the tumour cannot get in their way
Working with the cells outside the body
Working with the cells outside the body
We draw up to 90 ml of your blood. The immune cells are reprogrammed outside the body, and no systemic cytostatics are introduced into your bloodstream. That is why the method does not carry the side effects of chemotherapy: hair loss, liver damage, severe nausea.
Applicable at stages III–IV
Applicable at stages III–IV
Over 18 hours of laboratory incubation the cells regain the ability to recognize the tumour as a threat: they stop taking it for their own and receive an exact target. That is why the method is also used when the options of chemotherapy and radiation have been exhausted.
Targeted strike
Targeted strike
The trained immunocompetent cells are returned to the patient and attack tumour tissue in a targeted way. The method combines well with surgery: the immune response finds the micrometastases that may have been left behind.
Consolidation and long-term memory
Consolidation and long-term memory
A chemotherapy drug stops working as soon as it is cleared from the body. Trained immunity works differently: specific memory cells keep circulating in the blood and can respond to the disease returning years after the course.
Target therapy directions
Melanoma
Activation of your own cells to destroy metastases. Proven efficacy even at advanced stages.
Kidney cancer
Specific immune response against renal cell carcinoma without severe toxic burden.
Colorectal cancer
Personalized therapy for tumours of the colon and rectum as an addition to surgery and chemotherapy.
Lung cancer
Comprehensive impact on the tumor while preserving healthy tissues across various forms of lung cancer.
CNS tumors (gliomas)
Treatment of gliomas and astrocytomas with the patient's own primed immunocompetent cells.
Prostate cancer
Targeted inhibition of the tumor process and disease control to achieve long-term remission.
Breast cancer
Forming long-term antitumor defense, reducing the risks of relapses and metastasis.
Ovarian cancer
Adoptive therapy opening new treatment possibilities even when chemotherapy standards are exhausted.
Pancreatic cancer
Integrative techniques to enhance the immune response in aggressive forms of the disease.
Stomach cancer
Safe restoration of antitumor immunity for a targeted fight against cancer cells.
Thyroid cancer
Activation of antitumor immunity as an addition to surgical and radioiodine treatment.
Oncology Treatment Protocol
A cycle of four stages: the medical board, the course of injections, monitoring of the response and maintenance therapy.
Frequently asked questions
Discuss your situation
Leave your contact details. Our medical coordinator will contact you shortly to answer any questions.